Zhengdong Cai

9PUBLICATIONS
41CO-AUTHORS
Molecular targetsPredictive and prognostic markersNonlinear optics and spectroscopyCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 04, 2026
A single-molecule prodrug synergistically suppresses MYC-amplified osteosarcoma through sequential nitric oxide release and photodynamic therapy.

|May 05, 2026
UBA2-High Osteosarcoma Suppresses Immune Infiltration by Autophagy-Mediated MHC-I Degradation.

|Jan 30, 2026
TENT5A Maintains MYC mRNA Stability to Enhance Osteosarcoma Stemness.

Yining Tao, Qi Zhang, Haoyu Wang

|Dec 01, 2025
Clinical Application of an Ultrasonic Bone Scalpel in the Treatment of Osteoid Osteoma: A Single-Center Pilot Study.

He Dong, Jing Han, Binghui Yang

|May 17, 2024
Enhanced Osteosarcoma Immunotherapy via CaCO3 Nanoparticles: Remodeling Tumor Acidic and Immune Microenvironment for Photodynamic Therapy.

Yinghua Gao, Zhuoying Wang, Xinmeng Jin

|Nov 23, 2022
Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment.

Yafei Jiang, Jinzeng Wang, Mengxiong Sun

Pageof 2

Frequent Collaborators

5 joint publications

Yingqi Hua

3 joint publications

Wei Sun

2 joint publications

Jiakang Shen

2 joint publications

Weisong Zhao